ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 59 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | 0.0% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | -25.0% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,000 | -42.9% | 13,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $7,000 | -46.2% | 13,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $13,000 | -27.8% | 13,000 | 0.0% | 0.01% | -33.3% |
| Q2 2021 | $18,000 | -18.2% | 13,000 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $22,000 | +29.4% | 13,000 | -3.0% | 0.01% | +20.0% |
| Q4 2020 | $17,000 | -45.2% | 13,400 | -38.8% | 0.01% | -56.5% |
| Q3 2020 | $31,000 | -22.5% | 21,900 | -34.4% | 0.02% | -30.3% |
| Q2 2020 | $40,000 | +2.6% | 33,400 | 0.0% | 0.03% | -71.1% |
| Q1 2020 | $39,000 | +2.6% | 33,400 | +85.6% | 0.11% | +132.7% |
| Q4 2019 | $38,000 | – | 18,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |